Allogeneic hematopoietic transplantation following reduced-intensity-conditioning with 200cGy TBI and Fludarabine in MDS

被引：0
|
作者：
Al-Ali, H. K. [1 ]
Jaekel, N. [1 ]
Nehring, C. [1 ]
Krahl, R. [1 ]
Becker, C. [1 ]
Braunert, L. [1 ]
Leiblein, S. [1 ]
Franke, G. [1 ]
Lange, T. [1 ]
Niederwieser, D. [1 ]
机构：
[1] Univ Leipzig, Leipzig, Germany
来源：
ONKOLOGIE | 2011年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：301 / 301
页数：1
相关论文
共 50 条
  • [41] Retrospective comparison of hematopoietic stem cell transplantation following reduced-intensity conditioning with fludarabine/low-dose melphalan plus 4 Gy TBI versus fludarabine/ busulfan plus 4 Gy TBI
    Yuta Yamada
    Shuntaro Ikegawa
    Yuho Najima
    Yuya Atsuta
    Ryosuke Konuma
    Hiroto Adachi
    Atsushi Wada
    Yuya Kishida
    Tatsuya Konishi
    Akihito Nagata
    Satoshi Kaito
    Ryohei Nagata
    Yuma Noguchi
    Atsushi Marumo
    Junichi Mukae
    Kyoko Inamoto
    Takashi Toya
    Aiko Igarashi
    Takeshi Kobayashi
    Hisashi Sakamaki
    Kazuteru Ohashi
    Noriko Doki
    International Journal of Hematology, 2022, 115 : 244 - 254
  • [42] Reduced-intensity conditioning using fludarabine with either antithymocyte globulin and BU, or low-dose TBI allowing allogeneic hematopoietic SCT
    Cable, C.
    Buzzeo, M. P.
    Schold, J. D.
    Khan, S.
    Leather, H.
    Moreb, J.
    Jamieson, K.
    Scornik, J.
    Amdur, R. J.
    Wingard, J. R.
    Reddy, V.
    BONE MARROW TRANSPLANTATION, 2010, 45 (01) : 31 - 37
  • [43] Reduced-intensity conditioning using fludarabine with either antithymocyte globulin and BU, or low-dose TBI allowing allogeneic hematopoietic SCT
    C Cable
    M P Buzzeo
    J D Schold
    S Khan
    H Leather
    J Moreb
    K Jamieson
    J Scornik
    R J Amdur
    J R Wingard
    V Reddy
    Bone Marrow Transplantation, 2010, 45 : 31 - 37
  • [44] Fludarabine/Busulfan Plus Low Dose TBI As Reduced Intensity Conditioning in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Myeloid Malignancies
    Khalil, Manar Mohamed Ibrahim
    Messner, Hans A.
    Lipton, Jeffrey H.
    Kim, Dennis Dong Hwan
    Viswabandya, Auro
    Thyagu, Santhosh
    Deotare, Uday
    Michelis, Fotios V.
    BLOOD, 2016, 128 (22)
  • [45] Fludarabine and Busulfan versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma
    Epperla, Narendranath
    Ahn, Kwang Woo
    Armand, Philippe
    Jaglowski, Samantha
    Ahmed, Sairah
    Kenkre, Vaishalee P.
    Savani, Bipin
    Jagasia, Madan
    Shah, Nirav N.
    Fenske, Timothy S.
    Sureda, Anna
    Smith, Sonali M.
    Hamadani, Mehdi
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (01) : 78 - 85
  • [46] Allogeneic stem cell transplantation in MDS: reduced intensity conditioning and donor lymphocyte infusion
    Kroeger, N.
    LEUKEMIA RESEARCH, 2009, 33 : S28 - S28
  • [47] Impact of age on outcome after allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning with Fludarabine/Busulfan
    Bethge, W. A.
    Federmann, B.
    Helwig, A.
    Faul, C.
    Vogel, W.
    Kanz, L.
    ONKOLOGIE, 2012, 35 : 129 - 129
  • [48] Reduced-intensity conditioning with fludarabine and busulfan for allogeneic hematopoietic cell transplantation in elderly or infirm patients with advanced myeloid malignancies
    Dominik Schneidawind
    Birgit Federmann
    Corina Buechele
    Andrea Helwig
    Jörg Schmohl
    Wichard Vogel
    Christoph Faul
    Lothar Kanz
    Wolfgang A. Bethge
    Annals of Hematology, 2016, 95 : 115 - 124
  • [49] Engraftment kinetics and hematopoietic chimerism after reduced-intensity conditioning with fludarabine and treosulfan before allogeneic stem cell transplantation
    Blau, I. W.
    Schmidt-Hieber, Martin
    Leschinger, N.
    Goeldner, H.
    Knauf, W.
    Hopfenmueller, W.
    Thiel, E.
    Blau, O.
    ANNALS OF HEMATOLOGY, 2007, 86 (08) : 583 - 589
  • [50] Engraftment kinetics and hematopoietic chimerism after reduced-intensity conditioning with fludarabine and treosulfan before allogeneic stem cell transplantation
    I. W. Blau
    Martin Schmidt-Hieber
    N. Leschinger
    H. Göldner
    W. Knauf
    W. Hopfenmüller
    E. Thiel
    O. Blau
    Annals of Hematology, 2007, 86 : 583 - 589
12345